Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery
Recruiting
N/A
Interventional Study
Intrathecal Dexmedetomidine
Bupivacaine
Knee Orthopedic Surgery
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 120 (estimated)
- Sponsor
- Cairo University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to compare the duration of analgesia (as the primary outcome) and adverse effects (as the secondary outcome) after intrathecal administration of dexmedetomidine with hyperbaric bupivacaine to patients undergoing knee orthopedic surgery.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age from 18 to 65 years.
* American Society of Anesthesiologists (ASA) physical status I-II.
* Male patients scheduled for knee orthopedic surgery.
Exclusion Criteria:
* Patients with psychiatric disorders.
* History of drug addiction.
* Contraindication for regional anesthe…
Contacts